Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Elaina Vivian is a pioneering surgeon whose research centers on advancing minimally invasive techniques in hepatopancreatobiliary surgery, with a particular focus on robotic-assisted procedures. Her major contributions include demonstrating the safety and efficacy of robotic pancreaticoduodenectomy (RPD) compared to traditional open surgery, as evidenced by her landmark analysis of 102 fully robotic Whipple procedures (21 citations) and a propensity score-weighted survival analysis showing comparable outcomes for pancreatic ductal adenocarcinoma patients (11 citations). She has also pioneered robotic-assisted kidney auto-transplantation (RAKAT) as a novel treatment for nutcracker syndrome and loin pain haematuria syndrome (17 citations), expanding the boundaries of robotic surgery beyond conventional applications. Her work on minimally invasive liver resection in 214 cases (31 citations) further solidifies her expertise. Dr. Vivian has developed pretreatment prognostic models using the Albumin-Bilirubin score and systemic immune-inflammation indexes to guide neoadjuvant therapy decisions for pancreatic cancer patients (7 citations), and her recent meta-analysis on robotic versus open pancreaticoduodenectomy with vein resection (2025) continues to shape surgical practice. Her cumulative work, with over 90 citations, establishes her as a leading voice in the evidence-based adoption of robotic surgery for complex abdominal procedures.